Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chiara Calandrelli
Institutions:
Azienda Ospedaliero-Universitaria Careggi,
University of Florence
Observed institutions:
Azienda Ospedaliero-Universitaria Careggi,
University of Florence
ORCID:
0009-0001-2335-2100
Observed ORCID:
0009-0001-2335-2100
OpenAlex ID:
A5040172365
Immune Checkpoint Inhibitor-Related Pneumonitis in Renal Cell Carcinoma: Clinical Features, Mechanisms, and Lessons from Lung Cancer
2026
·
Kristian Shtembari
, Martina Catalano
, et al.
·
Biomolecules
·
2
PDF
Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study
2026
·
Giandomenico Roviello
, Elisabetta Gambale
, et al.
·
Scientific Reports
·
1
PDF
Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma
2026
·
Kannan Sridharan
, Giandomenico Roviello
, et al.
·
Figshare
Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma
2026
·
Kannan Sridharan
, Giandomenico Roviello
, et al.
·
Expert Opinion on Pharmacotherapy
Trastuzumab deruxtecan in HER2-expressing urothelial carcinoma: current evidence, biomarker challenges, and future therapeutic strategies
2026
·
Giandomenico Roviello
, Kristian Shtembari
, et al.
·
Expert Review of Anticancer Therapy
Post-ASCO 2026: resident-led highlights of the most clinically relevant studies in genitourinary oncology
2026
·
Martina Izzi
, Kristian Shtembari
, et al.
·
Future Oncology
Predictive biomarkers in cancer immunotherapy for genitourinary malignancies
2026
·
Alexandra Paulet
, Kristian Shtembari
, et al.
·
Critical Reviews in Oncology/Hematology
PDF
BRCA-Altered High-Volume mHSPC: Which Intensification Should Come First?
2026
·
Giandomenico Roviello
, Chiara Calandrelli
, et al.
·
Clinical Genitourinary Cancer
PDF
Embarking on a new era in high-risk biochemical recurrent prostate cancer: redefining early systemic intervention
2026
·
Martina Izzi
, Andrea Lapucci
, et al.
·
Pharmacology & Therapeutics
PDF
Case Report: Niraparib–abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five cases
2026
·
Ismaela Anna Vascotto
, Martina Catalano
, et al.
·
Frontiers in Oncology
PDF
Show more works
View as search
Works count:
10
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type